Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

Home page

Issue Number 528            May 31, 2005

CONTENTS OF THIS ISSUE

  1. New: ACIP releases recommendations on meningococcal disease prevention; CDC press release presents background information
  2. New: CDC fact sheet on meningococcal disease and vaccine includes information about newly licensed MCV4 vaccine
  3. New VIS translation: Spanish-language meningococcal vaccine VIS now available
  4. May issue of CDC's Immunization Works electronic newsletter is posted on the NIP website
  5. New: CDC announces broad availability of the 2005-06 edition of its travel-health guide, the "Yellow Book"
  6. Mark your calendar: Several CDC immunization courses are planned for summer and fall
  7. New translation: IAC's parent-education piece "After the Shots: What to do if your child has discomfort" now in Spanish
  8. June 14 teleconference to focus on reducing immunization disparities by working with ethnic physicians organizations

----------------------------------------------------------

Back to Top

---------------------------------------------------------------

ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
---------------------------------------------------------------

(1 of 8)
May 31, 2005
NEW: ACIP RELEASES RECOMMENDATIONS ON MENINGOCOCCAL DISEASE PREVENTION; CDC PRESS RELEASE PRESENTS BACKGROUND INFORMATION

On May 27, CDC published "Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)" as part of its series of MMWR Recommendations and Reports. On May 26, CDC issued a press release, "CDC Recommends Meningococcal Vaccine for Adolescents and College Freshmen." Excerpts from both follow.

ACIP RECOMMENDATIONS
The summary section of the ACIP recommendations is reprinted below.

***********************

Summary
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11-55 years. CDC's Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of young adolescents (defined in this report as persons aged 11-12 years) with MCV4 at the preadolescent healthcare visit (at age 11-12 years). Introducing a recommendation for MCV4 vaccination among young adolescents might strengthen the role of the preadolescent visit and have a positive effect on vaccine coverage among adolescents. For those persons who have not previously received MCV4, ACIP recommends vaccination before high school entry (at approximately age 15 years) as an effective strategy to reduce meningococcal disease incidence among adolescents and young adults. By 2008, the goal will be routine vaccination with MCV4 of all adolescents beginning at age 11 years. Routine vaccination with meningococcal vaccine also is recommended for college freshmen living in dormitories and for other populations at increased risk (i.e., military recruits, travelers to areas in which meningococcal disease is hyperendemic or epidemic, microbiologists who are routinely exposed to isolates of Neisseria meningitidis, patients with anatomic or functional asplenia, and patients with terminal complement deficiency). Other adolescents, college students, and persons infected with human immunodeficiency virus who wish to decrease their risk for meningococcal disease may elect to receive vaccine.

This report updates previous reports from ACIP concerning prevention and control of meningococcal disease. It also provides updated recommendations regarding use of the tetravalent meningococcal polysaccharide vaccine (MPSV4) and on antimicrobial chemoprophylaxis. . . .

***********************

To access a web-text (HTML) version of the complete recommendations, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5407a1.htm.

To access a ready-to-print (PDF) version of it, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5407.pdf.

To receive a FREE electronic subscription to MMWR (which includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html.


CDC PRESS RELEASE
The press release is reprinted below in its entirety.

***********************

For immediate release
May 26, 2005

CDC RECOMMENDS MENINGOCOCCAL VACCINE FOR ADOLESCENTS AND COLLEGE FRESHMEN

The Centers for Disease Control and Prevention (CDC) now recommends routine vaccination of children 11-12 years old, previously unvaccinated adolescents at high school entry, and college freshmen living in dormitories with the newly licensed meningococcal conjugate vaccine (MCV4). The new recommendation is designed to help achieve vaccination among those at highest risk for meningococcal disease. As the vaccine supply increases, CDC hopes, within three years, to recommend routine vaccination [of] all adolescents beginning at 11 years of age.

CDC recommends routine meningococcal vaccination for young adolescents at the pre-adolescent doctor visit at about age 11-12, and for those who have not previously been vaccinated, before entering high school at about age 15. CDC also recommends that college freshmen living in dormitories be immunized to reduce disease risk. College freshmen living in the close quarters of dormitories are at a higher risk for meningococcal disease compared with peers the same age who are not attending college. Also, all other adolescents who wish to reduce their risk of disease may elect to receive vaccine.

"This new vaccine can help protect adolescents and college students from meningococcal disease, said Dr. Stephen Cochi, acting director of CDC's National Immunization Program. "CDC encourages those at increased risk to take the opportunity to get vaccinated to help protect them from this serious disease."

Meningococcal disease strikes up to 3,000 Americans, killing 300 people every year. Ten to 12 percent of people with meningococcal disease die, and among survivors, up to 15 percent may suffer long-term permanent disabilities including hearing loss, limb amputation, or brain damage. The disease often begins with symptoms that can be mistaken for common illnesses, such as the flu. However, meningococcal disease is particularly dangerous because it progresses rapidly and can kill within hours.

This new vaccine should offer longer protection than previous vaccines, is a single shot, and the most common reaction is a sore arm. However, it does not protect people against meningococcal disease caused by serogroup B bacteria. This serogroup of bacteria causes one-third of meningococcal cases in the United States. More than half of the cases among infants under the age of 1 year are caused by type B, for which no vaccine is licensed or available in the United States.

The new meningococcal vaccine was licensed by the U.S. Food and Drug Administration (FDA) on January 14, 2005, for use in people 11-55 years of age. It is manufactured by Sanofi Pasteur and is marketed as Menactra.

For additional information on meningococcal disease, visit
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/meningococcal_g.htm.

***********************

To access a web-text (HTML) version of the press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r050526b.htm.
---------------------------------------------------------------

Back to Top

(2 of 8)
May 31, 2005
NEW: CDC FACT SHEET ON MENINGOCOCCAL DISEASE AND VACCINE INCLUDES INFORMATION ABOUT NEWLY LICENSED MCV4 VACCINE

On May 17, NIP posted on its website a new CDC fact sheet, Meningococcal Disease and Meningococcal Vaccine. It is intended to educate providers, NIP partners, and the public about meningococcal disease and the two vaccines that prevent it: tetravalent meningococcal conjugated vaccine (MCV4) and polysaccharide meningococcal vaccine (MPSV4).

To access a ready-to-print (PDF) version of the fact sheet, go to: http://www.cdc.gov/nip/vaccine/mening/mening_fs.pdf.

To access a web-text (HTML) version of it, go to:
http://www.cdc.gov/nip/vaccine/mening/mening_fs.htm.
---------------------------------------------------------------

Back to Top

(3 of 8)
May 31, 2005
NEW VIS TRANSLATION: SPANISH-LANGUAGE MENINGOCOCCAL VACCINE VIS NOW AVAILABLE

Dated 4/4/05, the interim meningococcal vaccine VIS is now available on the IAC website in Spanish. IAC gratefully acknowledges the California Department of Health Services for the translation.

To obtain a ready-to-copy (PDF) version of it, go to:
http://www.immunize.org/vis/sp_men05.pdf.

To obtain the VIS in English, go to:
http://www.immunize.org/vis/menin05.pdf.

For information about the use of VISs, and for VISs in a total of 32 languages, visit IAC's VIS web section at http://www.immunize.org/vis.
---------------------------------------------------------------

Back to Top

(4 of 8)
May 31, 2005
MAY ISSUE OF CDC'S IMMUNIZATION WORKS ELECTRONIC NEWSLETTER IS POSTED ON THE NIP WEBSITE

The May issue of Immunization Works, a monthly email newsletter published by CDC, is available on NIP's website. The newsletter offers members of the immunization community non-proprietary information about current topics. CDC encourages its wide dissemination.

Some of the information in the May issue appears elsewhere in this issue of IAC Express (see articles #2 and #6). Other information has appeared in previous issues of IAC Express. Following is the text of six articles we have not yet covered.

************************

OTHER IMMUNIZATION NEWS

2005 NATIONAL INFLUENZA VACCINE SUMMIT: The National Influenza Vaccine Summit, sponsored by CDC and the American Medical Association (AMA), was held on May 10-11, 2005, at the Palmer House Hilton Hotel in Chicago, IL. The National Influenza Summit is a partnership of stakeholders that addresses issues of influenza vaccination all year round. Attendees participate by invitation only. Throughout the year, the Summit participants collaborate to lend their efforts to address barriers that may reduce influenza vaccinations. These range from addressing uncertainties of the vaccine supply, communicating nationally on the benefits of influenza vaccination, and creating tools to facilitate the provision of vaccine.

Nine working groups currently exist within the Summit. Additionally, the Summit stands ready to add new working groups in response to new issues that may arise for the 2005-2006 influenza season.

MEETINGS, CONFERENCES, AND RESOURCES

NEW IMMUNIZATION FUNDING OPPORTUNITIES: CDC is seeking applicants for several new immunization funding opportunities. The projects vary and will target a range of audiences including older adults, children, and healthcare workers. All letters of intent are due in early to mid-June. For more information, please visit http://www.gpoaccess.gov/fr and enter this exact search string, including the quotes: "national immunization program" AND "funding".

THE NATIONAL VACCINE ADVISORY COMMITTEE (NVAC): NVAC will hold its next meeting on June 7-8, 2005, at the Hubert H. Humphrey Building in Washington, DC. The meeting is open to the general public. For more information, please visit http://www.hhs.gov/nvpo/nvac.

THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP): ACIP will hold its next meeting June 29-30, 2005, at the Marriott Century Center in Atlanta, Georgia. The meeting is open to the general public. For more information, please visit www.cdc.gov/nip/acip/default.htm.

NEW VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS) WEB ADDRESS: Please update your bookmarks to reflect the new web address for VAERS: www.vaers.hhs.gov. VAERS, the nation's vaccine safety passive surveillance system, is jointly administered by CDC and FDA. In order to better reflect the collaboration between these two HHS agencies, the web address (URL) for VAERS has changed. During the transition, the previous URL will automatically link to the new website. CDC and FDA will incorporate the new URL into documents over time. The VAERS mailing address (P.O.Box 1100, Rockville, MD 20849-1100) and toll-free number [(800)822-7967] will not change.

ATTENTION PHARMACISTS: Pharmacists continue to be important providers of adult immunizations. Because of that, NIP will begin offering more programs with continuing education credit for pharmacists. Pharmacy credit for You Call the Shots, Module One will become available in June 2005. Further, NIP seeks pharmacists who would like to volunteer to pilot test immunization training programs. If you are a pharmacist who is willing to volunteer a few hours to pilot upcoming immunization training programs, please contact Melissa Barnett at mbarnett2@cdc.gov.

************************

To access the complete May issue from the NIP website, go to:
http://www.cdc.gov/nip/news/newsltrs/imwrks/2005/200505.htm.
---------------------------------------------------------------

Back to Top

(5 of 8)
May 31, 2005
NEW: CDC ANNOUNCES BROAD AVAILABILITY OF THE 2005-06 EDITION OF ITS TRAVEL-HEALTH GUIDE, THE "YELLOW BOOK"

On May 24, CDC issued a press release announcing that the 2005-06 edition of "Health Information for International Travel" (aka, the "Yellow Book") is now available. Portions of the press release are reprinted below.

*******************

FOR FIRST TIME EVER, CDC TRAVEL HEALTH BOOK NOW MORE WIDELY AVAILABLE

The new edition of the "Yellow Book," the Centers for Disease Control and Prevention's (CDC) definitive guide on healthy travel, is now available for the first time to health professionals and everyday travelers through bookstores nationwide and online booksellers.

. . . . [O]fficially titled "Health Information for International Travel," [the book] serves as authoritative guide for vital pre-travel healthcare recommendations and essential information about health risks abroad. It is a resource for travel medicine specialists as well as primary healthcare providers who need to provide travel advice. The book also offers vaccination and medication information for disease risks by destination as well as helpful health hints for cruise ship travel, international adoptions, and a wide range of common travel problems such as motion sickness.

. . . .[S]aid Paul Arguin, chief of CDC's geographic medicine and health promotion branch: "The Yellow Book is an essential resource for anyone who provides travel medicine advice, especially healthcare providers, travel agents, airlines and cruise lines, as well as for the traveling public."

New health topics in this year's edition include

  • Changes in vaccine recommendations for travelers
  • Updated country-by-country malaria prevention information
  • Valuable advice on potential travel hazards such as natural disasters, animals, swimming, food and drink, altitude and motion sickness, sunburn, and more
  • Information on the special needs of travelers--from infants to nursing mothers to the elderly
  • Recommendations for recent U.S. immigrants returning home to visit friends and family
  • Improved maps and expanded indexing . . . .

*******************

To access the complete press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r050524.htm.
---------------------------------------------------------------

Back to Top

(6 of 8)
May 31, 2005
MARK YOUR CALENDAR: SEVERAL CDC IMMUNIZATION COURSES ARE PLANNED FOR SUMMER AND FALL

CDC recently announced the dates and times of three highly valuable and popular immunization education programs: (1) Current Issues in Immunization Net Conference, (2) Immunization Update 2005, and (3) Epidemiology & Prevention of Vaccine-Preventable Diseases. Following is brief information on each. Check future issues of IAC Express for further details.

1. CURRENT ISSUES IN IMMUNIZATION NET CONFERENCE.

SCHEDULED FOR July 14.

FORMAT: A live, 1-hour webcast combining an online visual presentation with simultaneous audio via telephone conference call. Participants can interact with the presenters through a live Q&A segment at the end of the program.

TOPICS: TBA; each Net Conference focuses on one or two late-breaking issues in immunization.

SPEAKERS: TBA.

REGISTRATION DEADLINE: TBA; pre-registration is required.

FOR ADDITIONAL INFORMATION, go to:
http://www.cdc.gov/nip/ed/netconference.htm.

2. IMMUNIZATION UPDATE 2005.

SCHEDULED FOR July 28 at 9-11:30 AM ET and rebroadcast from Noon-2:30PM ET.

FORMAT: A live satellite broadcast and webcast; both broadcasts will offer a live Q&A session in which participants nationwide can interact with the course instructors via toll-free telephone lines.

INTENDED FOR health professionals and their colleagues (in private practice or public health) who either administer vaccines or set policy for their offices, clinics, communicable disease, or infection control programs.

ANTICIPATED TOPICS include new recommendations for influenza vaccine and an update of the influenza vaccine supply, meningococcal conjugate vaccine, acellular pertussis vaccine for adolescents, and revised varicella vaccine recommendations.

FACULTY INCLUDES William L. Atkinson, MD, MPH; Donna Weaver, MN, RN; and Andrew Kroger, MD, MPH. All are with CDC's National Immunization Program.

REGISTRATION: Site registration begins on June 2; individual registration begins July 6.

FOR ADDITIONAL INFORMATION, go to:
http://www.phppo.cdc.gov/PHTN/immup2005/default.asp.

3. EPIDEMIOLOGY & PREVENTION OF VACCINE-PREVENTABLE DISEASES.

SCHEDULED FOR August 17-18 in Charleston, SC; November 14-15 in Sacramento, CA; November 17-18 in Torrance, CA.

FORMAT: An on-site two-day course.

FOR ADDITIONAL INFORMATION about the South Carolina course, contact Susan A. Smith, MN, RN, by phone at (803) 898-0869 or by email at smithsl@dhec.sc.gov; about both California courses, contact Sandra Jo Hammer by phone at (510) 540-2198 or by email at shammer@dhs.ca.gov.
---------------------------------------------------------------

Back to Top

(7 of 8)
May 31, 2005
NEW TRANSLATION: IAC'S PARENT-EDUCATION PIECE "AFTER THE SHOTS: WHAT TO DO IF YOUR CHILD HAS DISCOMFORT" NOW IN SPANISH

IAC recently posted the Spanish-language version of its two-page parent-education piece "After the Shots . . . What to do if your child has discomfort." We are grateful to the California Department of Health Services for the translation.

Revised and expanded in September 2004, the piece now includes a dosing schedule for ibuprofen, as well as acetaminophen.

To access a ready-to-copy (PDF) version of the Spanish-language piece, go to: http://www.immunize.org/catg.d/p4015-01.pdf.

To access a web-text (HTML) version of it, go to:
http://www.immunize.org/catg.d/p4015-01.htm.

To access a ready-to-copy (PDF) version of the English-language piece, go to: http://www.immunize.org/catg.d/p4015.pdf.

To access a web-text (HTML) version of it, go to:
http://www.immunize.org/nslt.d/n17/p4015.htm.
---------------------------------------------------------------

Back to Top

(8 of 8)
May 31, 2005
JUNE 14 TELECONFERENCE TO FOCUS ON REDUCING IMMUNIZATION DISPARITIES BY WORKING WITH ETHNIC PHYSICIANS ORGANIZATIONS

The National Immunization Coalition TA [technical assistance] Network has scheduled a teleconference on how immunization coalitions can work with ethnic physicians organizations to reduce racial/ethnic disparities in immunization. It will be held at 3PM ET on June 14. The network is a program of the Center for Health Communication, Academy for Educational Development (AED). The June 14 teleconference is a collaboration between AED and the California Coalition for Childhood Immunization.

The teleconference facilitator is Doretha Williams-Flournoy, project director, Network of Ethnic Physician Organizations, California Medical Association Foundation.

Teleconference participants will (1) increase their understanding of ethnic physician organizations' purpose, role, and resources; (2) identify techniques for effectively communicating and working with ethnic physicians; and (3) identify strategies for engaging local ethnic physician organizations in outreach programs designed to eliminate disparities in immunization coverage.

To register for the teleconference, email Katherine Shrout at kshrout@aed.org. In your email, include this message: "Sign me up for the Partnering with Ethnic Physician Organizations call."

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on May 31, 2005